Clari Vest Asset Management LLC Concert Pharmaceuticals, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.34 - $5.84 $6,510 - $8,760	-1,500 Reduced 1.43%	103,300 $603,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $204,120 - $463,644	72,900 Added 228.53%	104,800 $441,000
Q1 2019 May 13, 2019	SELL	$12.07 - $17.54 $1.17 Million - $1.71 Million	-97,306 Reduced 75.31%	31,900 $385,000
Q4 2018 Feb 05, 2019	BUY	$11.25 - $16.17 $228,307 - $328,153	20,294 Added 18.63%	129,206 $1.62 Million
Q3 2018 Nov 07, 2018	BUY	$12.82 - $17.88 $38,075 - $53,103	2,970 Added 2.8%	108,912 $1.62 Million
Q2 2018 Aug 10, 2018	SELL	$16.83 - $21.66 $45,609 - $58,698	-2,710 Reduced 2.49%	105,942 $1.78 Million
Q1 2018 May 08, 2018	BUY	$19.24 - $28.03 $1.81 Million - $2.64 Million	94,334 Added 658.85%	108,652 $2.49 Million
Q4 2017 Feb 13, 2018	BUY	$13.96 - $29.05 $199,879 - $415,937	14,318	14,318 $370,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.